LABIANA HEALTH S.A.EO-10 (8RK) — Capital Reinvestment Ratio
LABIANA HEALTH S.A.EO-10 (8RK) has a Capital Reinvestment Ratio of 0.42x as of December 2024, meaning it reinvests 0% of its operating cash flow (€7.19 Million) in capital expenditures (€3.05 Million). Check LABIANA HEALTH S.A.EO-10 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
LABIANA HEALTH S.A.EO-10 Capital Reinvestment Ratio (2021–2024)
This chart tracks LABIANA HEALTH S.A.EO-10's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see LABIANA HEALTH S.A.EO-10 (8RK) cash conversion ratio.
Annual Capital Reinvestment Ratio for LABIANA HEALTH S.A.EO-10 (2021–2024)
Year-by-year Capital Reinvestment Ratio for LABIANA HEALTH S.A.EO-10 from 2021 to 2024. See 8RK FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | €7.19 Million | €3.05 Million | ▼ -63.7% |
| 2022 | 1.17x | €4.68 Million | €5.45 Million | ▼ -4.5% |
| 2021 | 1.22x | €3.91 Million | €4.77 Million | — |